RxDoctor Payments Data

Amy Taub, MD

Dermatology · Lincolnshire, ILNPI 1215967765

Payments from drug & device makers

What this record shows

The money is spread across several categories — consulting fees (48.3%), speaking fees and food and beverage — rather than concentrated in one kind of arrangement. AbbVie accounts for 80.6% of it on its own, with 31 other manufacturers making up the rest. Reporting peaked in 2022 at $20,664 and has fallen 51.2% since, to $10,090 in 2025. Among dermatology clinicians in IL with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$81,492in general payments, 2019–2025

Across 484 payments — averaging $168.37 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$66K
  • Solta Medical, A Division Of Bausch Health US, LLC$6K
  • Merz North America, Inc.$3K
  • Galderma Laboratories, L.p.$3K
  • Sun Pharmaceutical Industries Inc.$592
  • Lilly USA, LLC$529
  • plus $4K from 26 others
$1,079,003in research payments, 2019–2025

Across 71 payments — averaging $15,197 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • AbbVie$1.1M

What the payments were for

  • Consulting fees$39,37648%
  • Speaking & faculty fees$26,64133%
  • Travel & lodging$2,2893%
  • Food & beverage$12,82516%
  • Education$3620%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$81,492 in reported general payments places this provider in the 90th percentile of 606 dermatology providers in Illinois.

See all dermatology providers in Illinois

Medicare billing

Part B allowed, 2024
$241,051
Medicare patients
438
Services billed
13,333

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Fluorouracil13$931
Clobetasol Propionate24$848
Metronidazole21$636
Betamethasone Dipropionate14$495
ValacyclovirValacyclovir Hcl39$393
Fluticasone Propionate19$290
Ketoconazole19$251
Triamcinolone Acetonide18$178
Doxycycline Hyclate17$129
Fluconazole16$83
Dexamethasone24$72
Minoxidil14$24

Paid to pharmacies, not to this prescriber.

Other dermatology in Lincolnshire

See the full list for Illinois

Where these figures come from

Is this you, or does something look wrong? →